Insulet
PODD
#1126
Rank
A$24.83 B
Marketcap
$354.14
Share price
0.24%
Change (1 day)
33.70%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Insulet (PODD) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$2.82 B

According to Insulet's latest financial reports the company's total liabilities are A$2.82 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insulet - Total liabilities on balance sheet (from 2005 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$2.72 B4.43%
2022-12-31A$2.60 B27.05%
2021-12-31A$2.05 B24.61%
2020-12-31A$1.64 B8.52%
2019-12-31A$1.51 B49.27%
2018-12-31A$1.01 B20.61%
2017-12-31A$0.84 B54.45%
2016-12-31A$0.54 B64.94%
2015-12-31A$0.33 B27.2%
2014-12-31A$0.26 B42.06%
2013-12-31A$0.18 B23.4%
2012-12-31A$0.14 B9.81%
2011-12-31A$0.13 B52.04%
2010-12-31A$88.89 M-33.07%
2009-12-31A$0.13 B14.48%
2008-12-31A$0.11 B163.55%
2007-12-31A$44.02 M-78.16%
2006-12-31A$0.20 B77.96%
2005-12-31A$0.11 B22.38%
2004-12-31A$92.56 M93.22%
2003-12-31A$47.9 M-25.37%
2002-12-31A$64.18 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$3.37 B 19.42%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.04 B-62.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$6.54 B 131.78%๐Ÿ‡บ๐Ÿ‡ธ USA
A$164.31 B 5,717.23%๐Ÿ‡บ๐Ÿ‡ธ USA
A$50.18 B 1,676.60%๐Ÿ‡บ๐Ÿ‡ธ USA
A$62.37 B 2,108.42%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
A$87.35 B 2,992.57%๐Ÿ‡บ๐Ÿ‡ธ USA